Frequency Therapeutics, Inc. (FREQ)
NASDAQ: FREQ · IEX Real-Time Price · USD
1.13
0.00 (0.00%)
May 26, 2022 4:00 PM EDT - Market closed
Balance Sheet (Annual)
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Year | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|
| Cash & Equivalents | 81.33 | 222.16 | 200.26 | 42.19 | 17.94 |
| Short-Term Investments | 51.07 | 0 | 17.2 | 0 | 0 |
| Cash & Cash Equivalents | 132.41 | 222.16 | 217.46 | 42.19 | 17.94 |
| Cash Growth | -40.40% | 2.16% | 415.43% | 135.21% | - |
| Other Current Assets | 2.34 | 2.9 | 3.9 | 0.75 | 0.02 |
| Total Current Assets | 134.75 | 225.06 | 221.36 | 42.94 | 17.96 |
| Property, Plant & Equipment | 36.87 | 37.84 | 1.76 | 1.51 | 1.73 |
| Long-Term Investments | 11.72 | 0 | 0 | 0 | 0 |
| Other Long-Term Assets | 2.02 | 1.82 | 0.1 | 0.1 | 0.1 |
| Total Long-Term Assets | 50.61 | 39.66 | 1.86 | 1.61 | 1.83 |
| Total Assets | 185.36 | 264.72 | 223.22 | 44.55 | 19.79 |
| Accounts Payable | 2.75 | 5.51 | 1.22 | 1.86 | 0.99 |
| Deferred Revenue | 0 | 14.07 | 51.05 | 0 | 0 |
| Current Debt | 2.58 | 0.4 | 0 | 0 | 0 |
| Other Current Liabilities | 6.1 | 6.66 | 0.51 | 1.91 | 1.23 |
| Total Current Liabilities | 11.43 | 26.63 | 52.78 | 3.77 | 2.23 |
| Long-Term Debt | 43.02 | 45.6 | 0 | 0 | 0 |
| Other Long-Term Liabilities | 0.09 | 0 | 3.08 | 0.35 | 0.51 |
| Total Long-Term Liabilities | 43.11 | 45.6 | 3.08 | 0.35 | 0.51 |
| Total Liabilities | 54.53 | 72.23 | 55.86 | 4.12 | 2.74 |
| Total Debt | 45.6 | 45.99 | 0 | 0 | 0 |
| Debt Growth | -0.86% | - | - | - | - |
| Common Stock | 310.97 | 287.86 | 236.19 | -2.97 | 0.28 |
| Retained Earnings | -180.09 | -95.4 | -68.89 | -49.09 | -29.92 |
| Comprehensive Income | -0.06 | 0.03 | 0.05 | 0 | 0 |
| Shareholders' Equity | 130.82 | 192.49 | 167.36 | -52.06 | -29.64 |
| Total Liabilities and Equity | 185.36 | 264.72 | 223.22 | -47.93 | -26.91 |
| Net Cash / Debt | 86.81 | 176.17 | 217.46 | 42.19 | 17.94 |
| Net Cash / Debt Growth | -50.72% | -18.99% | 415.43% | 135.21% | - |
| Net Cash Per Share | 2.53 | 5.46 | 25.14 | 27.57 | 25.52 |
| Working Capital | 123.32 | 198.43 | 168.58 | 39.16 | 15.73 |
| Book Value Per Share | 3.81 | 5.97 | 19.35 | -34.02 | -42.17 |
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).